寒武纪 reported revenue of ¥6.00B for the period ended 2026-06-30, +108.1% year on year. Net income was ¥2.31B, a 38.5% net margin on a 55.3% gross margin. The largest revenue line is 云端产品线 at 100% of the total. Free cash flow for the period was ¥-0.76B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.00B | +108.1% |
| Gross profit | ¥3.31B | — |
| Operating income | ¥2.30B | — |
| Net income | ¥2.31B | +122.7% |
| Gross margin | 55.3% | Net margin 38.5% |
| Revenue Q/Q | +7.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 云端产品线 | ¥5.99B | 100.0% |
| 边缘产品线 | ¥0.00B | 0.0% |
| 其他(补充) | ¥0.00B | 0.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.68B | 44.7% |
| R&D | ¥0.70B | 11.7% |
| SG&A | ¥0.11B | 1.8% |
| Tax & other | ¥-0.01B | -0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥18.20B |
| Total liabilities | ¥4.64B |
| Shareholders' equity | ¥13.56B |
| Equity / assets | 74.5% |
| Operating cash flow | ¥-0.52B |
| Capital expenditure | ¥0.24B |
| Free cash flow | ¥-0.76B |
| Cash conversion (OCF / net income) | 13% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
联影医疗 ・ 大全能源 ・ 华润微 ・ 阿特斯 ・ 百利天恒 ・ 芯原股份 ・ 中芯国际 ・ 特锐德 ・ 神州泰岳 ・ 乐普医疗 ・ 南风股份 ・ 探路者
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies